The global specialty medical chairs market size was estimated at USD 4.28 billion in 2016 and is anticipated to grow at a CAGR of 6.7% over the forecast period. Growing geriatric population is expected to accelerate the demand for specialty medical chairs over the forecast period.
According to a report published by the U.S. Census Bureau, the number of people aged 65 and above in the U.S. was approximately 46.2 million in 2014 and is expected to reach over 98 million by 2060. It is estimated that from 2025 to 2050, the older population is projected to almost double to 1.6 billion globally. Owing to the substantial increase in geriatric population, the patient base has increased, which has, in turn, increased the demand for these products. This consequent increase in demand is expected to drive market growth over the forecast period.
In addition, the introduction of technologically advanced and fully automated medical chairs is anticipated to serve the market with lucrative opportunities. Key players are offering customized chairs to meet patients’ & clinicians’ needs pertaining to examination and treatment of various diseases, thereby driving the growth of the market over the forecast period.
Moreover, increasing reimbursement policies and supportive regulatory framework is fueling the overall growth of this business. For instance, according to the Medicare Benefit Policy Manual, Chapter 11 a recliner (an adjustable chair) is covered under the same rate, for which Medicare pays to dialysis clinics. The End-Stage Renal Disease (ESRD) regulations state that patients should receive the same type of care and treatment at home as they receive in hospitals, thereby increasing the adoption of medical chairs in home care. Thus, the abovementioned factors are responsible for boosting overall growth.
Rehabilitation segment held the largest share of the market in 2016. They are the basic equipment required in hospitals, clinics or any other healthcare facility for handling geriatric population. The geriatric patient base is increasing. Owing to this, the adoption of rehabilitation chairs is very high. Increased adoption rate of these devices in developing regions, such as Asia Pacific and Latin America, are some of the factors responsible for the revenue generated by this segment.
Dialysis segment held the largest share in the examination chairs segment in 2016. Increasing incidence of chronic kidney diseases is responsible for the largest share held by dialysis chairs and is expected to propel the demand for these products in the coming years. Consistent technical advancements, such as increased weight capacity and less time required for attaining Trendelenburg position, are likely to stimulate the demand for this product, enabling specialty medical chairs market segment to retain its position during the forecast period.
The treatment segment is anticipated to grow at a lucrative rate during the forecast period. They are an indispensable part of any treatment procedure such as surgeries. A major benefit associated with these products is that they help patients achieve a comfortable posture, which gives doctors unrestricted access to various parts of a patient’s body. This equipment increases safety for both caregivers & patients and enhances patient relaxation. The market for treatment chairs is expected to grow steadily during the forecast period.
The rehabilitation segment is expected to grow at a steady rate during the forecast period. Rising incidence of paralysis and spinal injuries is resulting in an increase in geriatric and disabled population, which is expected to help maintain a steady demand for this product segment.
North America held the dominant share of the industry and was valued at USD 1.95 billion in 2016. This growth can be attributed to increasing geriatric population and well-developed reimbursement structure, contributing to the overall revenue in this region. Rising prevalence of lifestyle-associated disorders is increasing the patient base for these products, thereby boosting the market in this region.
Increase in the number of dental, ophthalmic, and ENT clinics across the U.S. and Canada is pushing the demand for specialty medical chairs. In addition, the presence of key market players, advanced healthcare infrastructure, the rise in geriatric population, high disposable income, and vast lifestyle changes are contributing to overall growth of the industry.
Asia Pacific region is anticipated to grow at an exponential rate of 7.5%, owing to increasing geriatric population, which indicates a substantial socioeconomic burden in this region. An unprecedented increase in older population is anticipated to reduce workforce and increase public healthcare spending in this region, consequentially increasing the adoption of specialty medical chairs. According to a report published by the U.S. Census Bureau, Japan has the highest percentage of the aged population in the world.
Furthermore, the presence of supportive international organizations such as the United Nations Population Fund, which aims at providing support to aging countries for developing and implementing national strategies and policies, is also a market driving factor. Presence of high untapped opportunities, rising disposable income, and continuous R&D activities by major players to develop innovative products are factors expected to bolster the market growth over the coming years.
The industry is progressing owing to the increasing demand for comfort, increased access to various parts of a patient’s body, and better treatment options. These factors have attracted several local and international medical devices manufacturers to invest in this business.
Some of the key players in this market are A-dec, Inc.; ACTIVEAID, Inc.; DentalEZ, Inc.; Fresenius Medical Care AG & Co. KGaA; Topcon Corporation; Midmark Corp.; Danaher (KaVo Dental GmbH); Dentsply Sirona; PLANMECA OY; and Hill Laboratories Company. The competitive milieu has resulted in improved treatment delivery, better products, and increased patient safety.
The industry is competitive in nature with key players involved in mergers & acquisitions, new product development, collaborations & partnerships, and expansion strategies to augment market penetration. For instance, in June 2017, Dentsply Sirona entered into a distribution agreement with Henry Schein Canada, Inc. with an aim to expand its distribution network in Canada.
The increase in the number of industry participants is expected to increase the competition in the near future. Owing to this fact, competitive rivalry in the industry is expected to be high during the forecast period.
Report Attribute |
Details |
Market size value in 2020 |
USD 5,488.9 million |
Revenue forecast in 2025 |
USD 7,657.2 million |
Growth Rate |
CAGR of 6.7% from 2017 to 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2015 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain Japan; China; India; Brazil; Mexico; South Africa; Saudi Arabia |
Key companies profiled |
A-dec, Inc.; ACTIVEAID, Inc.; DentalEZ, Inc.; Fresenius Medical Care AG & Co. KGaA; Topcon Corporation; Midmark Corp.; Danaher (KaVo Dental GmbH); Dentsply Sirona; PLANMECA OY; and Hill Laboratories Company |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global specialty medical chairs market on the basis of product and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Examination Chairs
Birthing
Cardiac
Blood Drawing
Dialysis
Mammography
Treatment Chairs
Ophthalmic
ENT
Dental
Others
Rehabilitation Chairs
Pediatric
Bariatric
Geriatric
Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
Saudi Arabia
b. The global specialty medical chairs market size was estimated at USD 5,151.8 million in 2019 and is expected to reach USD 5,488.9 million in 2020.
b. The global specialty medical chairs market is expected to grow at a compound annual growth rate of 6.7% from 2017 to 2025 to reach USD 7,657.2 million by 2025.
b. North America dominated the global specialty medical chairs market with a share of 45.6% in 2016. This is attributable to the rising geriatric population, and well-developed reimbursement structure.
b. Some key players operating in the global specialty medical chairs market include A-dec, Inc.; ACTIVEAID, Inc.; DentalEZ, Inc.; Fresenius Medical Care AG & Co. KGaA; Topcon Corporation; Midmark Corp.; Danaher (KaVo Dental GmbH); Dentsply Sirona; PLANMECA OY; and Hill Laboratories Company.
b. Key factors that are driving the market growth include increasing aging population, rising number of dental, ophthalmic, and ENT clinics, and advanced healthcare infrastructure.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.